Purpose: To evaluate the risk factors for elevated intraocular pressure (IOP) after pars plana vitrectomy (PPV) with silicone oil injection (SOI). Procedures: This prospective interventional study included 254 consecutive eyes receiving PPV with SOI. Results: Elevated IOP developed in 48% of the eyes postoperatively. The onset of IOP elevation was early (≤1 week) in 61.5% of the eyes, intermediate (1–6 weeks) in 28.7%, and late (> 6 weeks) in 9.8%. The incidence of IOP elevation was higher with primary uncomplicated rhegmatogenous retinal detachment than with tractional detachment (p = 0.01). Pseudophakia, high myopia, and high preoperative IOP were found to have higher incidences of ocular hypertension, whereas diabetic patients had a lower incidence. Conclusion: IOP elevation is a common complication following silicone oil (SO) tamponade. Risk factors for ocular hypertension development are pseudophakia, high myopia, high preoperative IOP, and low-viscosity SO.

Keywords:
Pars plana vitrectomy, Silicone oil, Ocular hypertension, Diabetic vitreo-retinopathy, Diseases of the retina and vitreous, Glaucoma, Surgery of the retina and vitreous, Tamponade, Tonometry
1.
Cibis PA, Becker B, Okun E, Canaan S: The use of liquid silicone in retinal detachment surgery. Arch Ophthalmol 1962; 68: 590–599.
2.
Azen SP, Scott IU, Flynn HW, Lai MY, Topping TM, Benati L, et al: Silicone oil in the repair of complex retinal detachments. A prospective observational multicenter study. Ophthalmology 1998; 105: 1587–1597.
3.
Scott IU, Flynn HW, Lai M, Chang S, Azen SP: First operation anatomic success and other predictors of postoperative vision after complex retinal detachment repair with vitrectomy and silicone oil tamponade. Am J Ophthalmol 2000; 130: 745–750.
4.
Mathis A, Pagot V, Gazagne C, Malecaze F: Giant retinal tears. Surgical techniques and results using perfluorodecalin and silicone oil tamponade. Retina 1992; 12:S7–S10.
5.
Abrams GW, Azen SP, McCuen BW, Flynn HW, Lai MY, Ryan SJ: Vitrectomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy: results of additional and long-term follow-up. Silicone Study report 11. Arch Ophthalmol 1997; 115: 335–344.
6.
Mancino R, Ciuffoletti E, Martucci A, Aiello F, Cedrone C, Cerulli L, et al: Anatomical and functional results of macular hole retinal detachment surgery in patients with high myopia and posterior staphyloma treated with perfluoropropane gas or silicone oil. Retina 2013; 33: 586–592.
7.
Honavar SG, Goyal M, Majji AB, Sen PK, Naduvilath T, Dandona L: Glaucoma after pars plana vitrectomy and silicone oil injection for complicated retinal detachments. Ophthalmology 1999; 106: 169–176; discussion 177.
8.
Barr CC, Lai MY, Lean JS, Linton KL, Trese M, Abrams G, et al: Postoperative intraocular pressure abnormalities in the Silicone Study. Silicone Study Report 4. Ophthalmology 1993; 100: 1629–1635.
9.
Romano V, Cruciani M, Semeraro F, Costagliola C, Romano MR: Development of ocular hypertension secondary to tamponade with light versus heavy silicone oil: a systematic review. Indian J Ophthalmol 2015; 63: 227–232.
10.
Antoun J, Azar G, Jabbour E, Kourie HR, Slim E, Schakal A, et al: vitreoretinal surgery with silicone oil tamponade in primary uncomplicated rhegmatogenous retinal detachment: clinical outcomes and complications. Retina 2016; 36: 1906–1912.
11.
Wang L, Liu J, Lu T: Clinical analysis of early and mid-late elevated intraocular pressure after silicone oil injection. Eye Sci 2014; 29: 85–89.
12.
Han DP, Lewis H, Lambrou FH, Mieler WF, Hartz A: Mechanisms of intraocular pressure elevation after pars plana vitrectomy. Ophthalmology 1989; 96: 1357–1362.
13.
Miller JB, Papakostas TD, Vavvas DG: Complications of emulsified silicone oil after retinal detachment repair. Semin Ophthalmol 2014; 29: 312–318.
14.
Wu L, Berrocal MH, Rodriguez FJ, Maia M, Morales-Canton V, Figueroa M, et al: Intraocular pressure elevation after uncomplicated pars plana vitrectomy: results of the Pan American Collaborative Retina Study Group. Retina 2014; 34: 1985–1989.
15.
Zafar S, Shakir M, Mahmood SA, Amin S, Iqbal Z: Comparison of 1000-centistoke versus 5000-centistoke silicone oil in complex retinal detachment surgery. J Coll Physicians Surg Pak 2016; 26: 36–40.
16.
Al-Jazzaf AM, Netland PA, Charles S: Incidence and management of elevated intraocular pressure after silicone oil injection. J Glaucoma 2005; 14: 40–46.
17.
Lalezary M, Kim SJ, Jiramongkolchai K, Recchia FM, Agarwal A, Sternberg P: Long-term trends in intraocular pressure after pars plana vitrectomy. Retina 2011; 31: 679–685.
18.
Petersen J, Ritzau-Tondrow U: Chronic glaucoma following silicone oil implantation: a comparison of 2 oils of differing viscosity. Fortschritte Ophthalmol Z Dtsch Ophthalmol Ges 1988; 85: 632–634.
19.
Scott IU, Flynn HW, Murray TG, Smiddy WE, Davis JL, Feuer WJ: Outcomes of complex retinal detachment repair using 1000- vs. 5000-centistoke silicone oil. Arch Ophthalmol 2005; 123: 473–478.
20.
Lakits A, Nennadal T, Scholda C, Knaus S, Gruber H: Chemical stability of silicone oil in the human eye after prolonged clinical use. Ophthalmology 1999; 106: 1091–1100.
21.
Chang S: LXII Edward Jackson lecture: open angle glaucoma after vitrectomy. Am J Ophthalmol 2006; 141: 1033–1043.
22.
Toyokawa N, Kimura H, Matsumura M, Kuroda S: Incidence of late-onset ocular hypertension following uncomplicated pars plana vitrectomy in pseudophakic eyes. Am J Ophthalmol 2015; 159: 727–732.
23.
Mendoza AJ, Fernandez CF, Arevalo J: Glaucoma after pars plana vitrectomy and silicone oil injection for complicated retinal detachments. Invest Ophthalmol Vis Sci 2003; 44: 3314–3314.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.